Posts

Showing posts from November, 2025

Governments continue to obscure COVID-19 vaccine data amid rising concerns over excess deaths

Image
    Coronavirus By Patrick Lewis  // Nov 18, 2025 The FDA initially tried to hide Pfizer's COVID vaccine trial data for 55 years, then extended it to 75 years, claiming insufficient staff. A federal judge forced partial disclosure, but the FDA continues resisting full transparency. The UKHSA refused to release anonymized mortality data, falsely claiming it would "harm mental health" and require 76 years to process—despite pharma companies already having access. VAERS reports 31,569 deaths, 53,302 myocarditis cases and 59,127 permanently disabled—likely undercounted by 95% to 99%. Australia quietly budgeted $77 million for vaccine injury payouts in 2023 alone. Peer-reviewed studies link vaccines to increased cancer rates, immune dysfunction and serious adverse events, yet governments dismiss findings as "long COVID" or pre-existing conditions. From the U.S. to the U.K., governments are actively hiding autopsy reports, delaying FOIA requests and blocking independe...

A veil of secrecy: U.K. health agency withholds data amid excess death concerns

Image
  Bad science By Willow Tohi  // Nov 17, 2025 The U.K. Health Security Agency is refusing to publicly release data that could reveal a potential link between COVID-19 vaccination dates and excess deaths. A cross-party group of MPs and the campaign group UsForThem have demanded transparency, noting the data was shared with pharmaceutical companies. The UKHSA defends its decision, citing concerns over public distress, misinformation and patient confidentiality. Critics have accused the agency of a "cover-up" and compared its stance to the early days of the infected blood scandal. The Information Commissioner has ruled in favor of the UKHSA, upholding its right to withhold the anonymized dataset. In a move that has ignited accusations of a governmental cover-up, the U.K. Health Security Agency (UKHSA) is refusing to release critical data that could illuminate the causes behind the nation’s persistently high excess death rates. Despite sharing the same information with pharmaceut...